The valuation impact of Vivos Therapeutics VVOS earnings quality VVOS Vivos Therapeutics Q4 Earnings Miss Wider Loss Z Zillow beats Q1 estimates by 14 with 155 revenue growth yet shares retreat 2 The competitive moat visible in Boxlight BOXL earnings Q4 2025 Below Expectations CINF Cincy Fin Q1 2026 EPS outpaces analyst forecasts stock notches modest daily gain after results release UNB Q2 2025 Earnings Solid EPS Performance Amidst Quiet Quarter Magyar Bancorp Inc MGYR Q4 2025 Earnings Bank Reports EPS of 040 Amid Quiet Quarter LIXT Q4 2024 Earnings Biotech Reports Net Loss Stock Declines BRBS Q1 2026 Earnings Return to Profitability with Positive EPS of 002 LBRDA Q3 2025 Earnings EPS Surges Past Estimates Despite Broadband Headwinds UFCS Q1 2026 Earnings EPS Surges Past Estimates by 37 as Stock Declines